Abstract Natural killer (NK)/T-cell lymphomas and NK-cell leukemias are aggressive
malignancies. Occurring worldwide, they show a predilection for Asian and South American …

Natural killer (NK)-cell malignancies are uncommon diseases. Previously known as
polymorphic reticulosis or angiocentric T-cell lymphomas, they are classified by the World …

Background The clinical outcome of extranodal natural killer T-cell lymphoma (ENKTL) has
improved substantially as a result of new treatment strategies with non-anthracycline-based …

This study aimed to assess the efficacy and safety of treatment with avelumab, an anti–
programmed death ligand 1 (PD-L1) antibody, in patients with relapsed or refractory …

Purpose Patients with natural killer T (NK/T)-cell lymphomas have poor survival outcome,
and for this condition there is no optimal therapy. The purpose of this study was to design a …

The present guidelines cover the systemic subtypes of primary nodal and primary extranodal
peripheral T-cell lymphomas (PTCLs). ESMO guidelines for primary cutaneous T-cell …

Purpose On the basis of the benefits of frontline radiation in early-stage, extranodal, natural
killer (NK)/T-cell lymphoma (ENKTL), we conducted a phase II trial of concurrent …

Purpose To explore a more effective treatment for localized nasal natural killer (NK)/T-cell
lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy. Patients and …

Nasal natural killer (NK) cell lymphoma is rare, so that its optimal therapy, long-term
outcome, and prognostic factors are unclear. Data on 52 men and 15 women with well …

Purpose The optimal therapy remains unclear for nasal natural killer (NK)/T–cell lymphoma.
The purpose of this study is to analyze the outcome of radiotherapy as the primary treatment …